Clinical Approach to The Diagnosis of Hereditary and Acquired Neuromuscular Diseases
DOI:
https://doi.org/10.61788/njn.v1i27.05Keywords:
neuromuscular diseases, hereditary phenomena, multisystem impact, diagnosisAbstract
Progressive groups of neuromuscular diseases (NMDs), including hereditary and acquired forms, are heterogeneous pathologies affecting lower motoneurons, resulting in multisystem changes and complicating diagnosis. Diseases such as myotonic dystrophy, myasthenia gravis, and spinal muscular atrophy are characterised by a variety of symptoms and require a comprehensive approach to diagnosis, including molecular genetic development and neuroimaging. In Tajikistan, the increased mortality rate of NMDs may be related to hereditary predisposition and environmental factors, which necessitates the development of diagnostic and educational programs. The present study aims to investigate the incidence, risk factors, and diagnostic methods of NMDs in Tajikistan. The findings show that improved diagnosis and increased detection of the incidence of the disease allow to provide better medical care and improve the quality of life of patients.
References
Кушнир Г.М., Иошина Н.Н., Абибулаев С.А., Савчук Е.А. и др. Спинальные мышечные атрофии с поздним дебютом: обзор литературы и описание клинического случая // Таврический медико-биологический вестник. - 2017. - Т. 20. - №. 3-1. - С. 110-115.
Евтушенко С.К., Шаймурзин М.Р., Евтушенко И.С. Новые современные технологии в терапии нейромышечных заболеваний, направленные на замедление их прогрессирования // Международный неврологический журнал. - 2009. - №. 4. - С. 9-19.
Garg N., Park S.B., Vucic S., Yiannikas C. et al. Differentiating lower motor neuron syndromes // Journal of neurology, neurosurgery, and psychiatry, 2017, 88(6), 474-483. doi: 10.1136/jnnp-2016-313526
Ozsarlak O., Schepens E., Parizel P.M., Van Goethem J.W. et al. Hereditary neuromuscular diseases // European journal of radiology, 2001, 40(3), 184-197. doi: 10.1016/s0720-048x(01)00399-0
Nakamura K, Sekijima Y. [Genetic counseling and predictive testing for hereditary neuromuscular diseases] // Rinsho Shinkeigaku (Clinical Neurology). 2021 Sep 28;61(9):588-593. Japanese. doi: 10.5692/clinicalneurol.cn-001608
Coppedè F. Special Issue "Genetics and Epigenetics of Neuromuscular Diseases" // Genes (Basel). 2023 Jul 26;14(8):1522. doi: 10.3390/genes14081522
Saffari A, Weiler M, Hoffmann GF, Ziegler A. Gentherapien für neuromuskuläre Erkrankungen [Gene therapies for neuromuscular diseases] // Nervenarzt. 2019 Aug;90(8):809-816. German. doi: 10.1007/s00115-019-0761-z
Coppedè F. Epigenetics of neuromuscular disorders // Epigenomics. 2020 Dec;12(23):2125-2139. doi: 10.2217/epi-2020-0282
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 National Association of Neurologists

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.



